Opportunity

Imatinib Tablets

Response due

October 30, 2026

Buyer: Nac Pharmaceuticals (36E797)
Agency: Nac Pharmaceuticals (36E797)
Estimated value: Not stated

Key dates

Posted: October 16, 2026
Response due: October 30, 2026

Who is this buyer

Nac Pharmaceuticals (36E797)

Organization

Nac Pharmaceuticals (36E797)

Buying history

Records31 total
Opportunities / awards3 / 7
Value range$1,932,252 – $436,529,696
ActiveJune 10, 2026 – October 22, 2026

What they buy

Clinical (31)

Set-asides used

No Set aside used (1)

Who holds their work today

GOLDEN STATE MEDICAL SUPPLY, INC.2 wins · $37,369,721 · last September 8, 2026
AVKARE LLC1 win · $1,932,252 · last July 20, 2026

Also open from this buyer

Sacubitril/Valsartan Tablets (VA-27-00014055)Due November 3, 2026 · Clinical
Tacrolimus CapsulesClinical

View source document →

Source link on sam.gov.

Source record

Buyer type: Federal
Jurisdiction: Federal (US)
Category: Clinical
Set-aside: Not stated
NAICS: 325412
PSC: 6505